Zivo Bioscience, Inc. SEC filings ZIVO
Zivo Bioscience, Inc. has 757 filings in SEC EDGAR's recent list, going back to Apr 20, 2000. Its latest annual report, Form ARS, was filed on Apr 25, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Mar 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 10-Q/A | Amended quarterly report | Apr 21, 2022 | Sep 30, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 13, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Oct 28, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 7, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 13, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | Apr 23, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Oct 19, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 11, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 12, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 14, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 12, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 13, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 13, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 13, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 13, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Nov 14, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 14, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 14, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 12, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 13, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 6, 2013 | Mar 31, 2013 |
| 10-Q/A | Amended quarterly report | Nov 19, 2012 | Sep 30, 2012 |
| 10-Q | Quarterly report | Nov 14, 2012 | Sep 30, 2012 |
| 10-Q/A | Amended quarterly report | Aug 31, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | Aug 14, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 15, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Nov 21, 2011 | Sep 30, 2011 |
| 10-Q/A | Amended quarterly report | Sep 13, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | Aug 22, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | May 20, 2011 | Mar 31, 2011 |
| 10-Q/A | Amended quarterly report | Mar 18, 2011 | Sep 30, 2010 |
| 10-Q/A | Amended quarterly report | Mar 18, 2011 | Jun 30, 2010 |
| 10-Q | Quarterly report | Nov 15, 2010 | Sep 30, 2010 |
| 10-Q | Quarterly report | Aug 12, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | May 17, 2010 | Mar 31, 2010 |
| 10-Q | Quarterly report | Nov 17, 2009 | Sep 30, 2009 |
| 10-Q | Quarterly report | Aug 14, 2009 | Jun 30, 2009 |
| 10-Q | Quarterly report | Jun 15, 2009 | Mar 31, 2009 |
| 10-Q | Quarterly report | Nov 14, 2008 | Sep 30, 2008 |
| 10-Q | Quarterly report | Aug 14, 2008 | Jun 30, 2008 |
| 10-Q/A | Amended quarterly report | May 16, 2008 | Mar 31, 2008 |
| 10-Q | Quarterly report | May 15, 2008 | Mar 31, 2008 |
Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZIVO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Bloomfield Hills, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1101026
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC (until Oct 16, 2014); WESTERN GLORY HOLE INC (until Jan 26, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.